Shaw, L. M. et al. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann. Neurol. 65, 403–413, https://doi.org/10.1002/ana.21610 (2009).
McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269, https://doi.org/10.1016/j.jalz.2011.03.005 (2011).
Jack, C. R. Jr. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14, 535–562, https://doi.org/10.1016/j.jalz.2018.02.018 (2018).
Blennow, K. Biomarkers in Alzheimer’s disease drug development. Nat. Med. 16, 1218–1222, https://doi.org/10.1038/nm.2221 (2010).
Bateman, R. J. et al. Clinical and biomarker changes in dominantly…
